Global Aminoglycosides Antibiotics Market Size, Share, Trends and Forecast 2022-2030

Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics.
Industry Insights

Due to the COVID-19 pandemic, the global Aminoglycosides Antibiotics market size is estimated to be worth US$ 1051.5 million in 2021 and is forecast to a readjusted size of US$ 1244.9 million by 2028 with a CAGR of 2.4% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Aminoglycosides Antibiotics market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Aminoglycosides Antibiotics landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

The classification of Aminoglycosides Antibiotics includes Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin and Others. In addition, the proportion of Neomycin in 2019 is about 26%, and Etimicin mainly sales in China.

Aminoglycosides Antibiotics is widely used for Hospital, Clinic, Post Care Facility, Government & Military and Others. The most proportion of Aminoglycosides Antibiotics is for clinic, and the proportion in 2019 is about 35%.

Europe is the largest consumption place, with a consumption market share nearly 26% in 2019. Following Europe, China is the second largest consumption place with the consumption market share of about 16%.

Jemicare, Teva, Novartis Pharmaceuticals, Fangyuan-pharma, Aike Pharmaceutical, Cipla, etc. are the leaders of the industry.

This report focuses on Aminoglycosides Antibiotics volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Aminoglycosides Antibiotics market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China, India and Middle East & Africa, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Aminoglycosides Antibiotics market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Neomycin

Tobramycin

Gentamicin

Amikacin

Etimicin

Others

Segment by Application

Hospital

Clinic

Post Care Facility

Government & Military

Others

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Jemicare

Teva

Novartis

Fangyuan-pharma

Aike Pharmaceutical

Cipla

Pfizer

Fresenius Kabi

Sun Pharma

Hikma

Lannett Company

1 Aminoglycosides Antibiotics Market Overview
1.1 Product Overview and Scope of Aminoglycosides Antibiotics

1.2 Aminoglycosides Antibiotics Segment by Type

1.2.1 Global Aminoglycosides Antibiotics Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Neomycin

1.2.3 Tobramycin

1.2.4 Gentamicin

1.2.5 Amikacin

1.2.6 Etimicin

1.2.7 Others

1.3 Aminoglycosides Antibiotics Segment by Application

1.3.1 Global Aminoglycosides Antibiotics Sales Comparison by Application: (2022-2028)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Post Care Facility

1.3.5 Government & Military

1.3.6 Others

1.4 Global Aminoglycosides Antibiotics Market Size Estimates and Forecasts

1.4.1 Global Aminoglycosides Antibiotics Revenue 2017-2028

1.4.2 Global Aminoglycosides Antibiotics Sales 2017-2028

1.4.3 Aminoglycosides Antibiotics Market Size by Region: 2017 Versus 2021 Versus 2028

2 Aminoglycosides Antibiotics Market Competition by Manufacturers

2.1 Global Aminoglycosides Antibiotics Sales Market Share by Manufacturers (2017-2022)

2.2 Global Aminoglycosides Antibiotics Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Aminoglycosides Antibiotics Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Aminoglycosides Antibiotics Manufacturing Sites, Area Served, Product Type

2.5 Aminoglycosides Antibiotics Market Competitive Situation and Trends

2.5.1 Aminoglycosides Antibiotics Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Aminoglycosides Antibiotics Players Market Share by Revenue

2.5.3 Global Aminoglycosides Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Aminoglycosides Antibiotics Retrospective Market Scenario by Region

3.1 Global Aminoglycosides Antibiotics Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Aminoglycosides Antibiotics Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Aminoglycosides Antibiotics Market Facts & Figures by Country

3.3.1 North America Aminoglycosides Antibiotics Sales by Country

3.3.2 North America Aminoglycosides Antibiotics Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Aminoglycosides Antibiotics Market Facts & Figures by Country

3.4.1 Europe Aminoglycosides Antibiotics Sales by Country

3.4.2 Europe Aminoglycosides Antibiotics Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Aminoglycosides Antibiotics Market Facts & Figures by Region

3.5.1 Asia Pacific Aminoglycosides Antibiotics Sales by Region

3.5.2 Asia Pacific Aminoglycosides Antibiotics Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Aminoglycosides Antibiotics Market Facts & Figures by Country

3.6.1 Latin America Aminoglycosides Antibiotics Sales by Country

3.6.2 Latin America Aminoglycosides Antibiotics Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Aminoglycosides Antibiotics Market Facts & Figures by Country

3.7.1 Middle East and Africa Aminoglycosides Antibiotics Sales by Country

3.7.2 Middle East and Africa Aminoglycosides Antibiotics Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Aminoglycosides Antibiotics Historic Market Analysis by Type

4.1 Global Aminoglycosides Antibiotics Sales Market Share by Type (2017-2022)

4.2 Global Aminoglycosides Antibiotics Revenue Market Share by Type (2017-2022)

4.3 Global Aminoglycosides Antibiotics Price by Type (2017-2022)

5 Global Aminoglycosides Antibiotics Historic Market Analysis by Application

5.1 Global Aminoglycosides Antibiotics Sales Market Share by Application (2017-2022)

5.2 Global Aminoglycosides Antibiotics Revenue Market Share by Application (2017-2022)

5.3 Global Aminoglycosides Antibiotics Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Jemicare

6.1.1 Jemicare Corporation Information

6.1.2 Jemicare Description and Business Overview

6.1.3 Jemicare Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Jemicare Aminoglycosides Antibiotics Product Portfolio

6.1.5 Jemicare Recent Developments/Updates

6.2 Teva

6.2.1 Teva Corporation Information

6.2.2 Teva Description and Business Overview

6.2.3 Teva Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Teva Aminoglycosides Antibiotics Product Portfolio

6.2.5 Teva Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Corporation Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Novartis Aminoglycosides Antibiotics Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 Fangyuan-pharma

6.4.1 Fangyuan-pharma Corporation Information

6.4.2 Fangyuan-pharma Description and Business Overview

6.4.3 Fangyuan-pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Fangyuan-pharma Aminoglycosides Antibiotics Product Portfolio

6.4.5 Fangyuan-pharma Recent Developments/Updates

6.5 Aike Pharmaceutical

6.5.1 Aike Pharmaceutical Corporation Information

6.5.2 Aike Pharmaceutical Description and Business Overview

6.5.3 Aike Pharmaceutical Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2017-2022)

6.5.4 Aike Pharmaceutical Aminoglycosides Antibiotics Product Portfolio

6.5.5 Aike Pharmaceutical Recent Developments/Updates

6.6 Cipla

6.6.1 Cipla Corporation Information

6.6.2 Cipla Description and Business Overview

6.6.3 Cipla Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2017-2022)

6.6.4 Cipla Aminoglycosides Antibiotics Product Portfolio

6.6.5 Cipla Recent Developments/Updates

6.7 Pfizer

6.6.1 Pfizer Corporation Information

6.6.2 Pfizer Description and Business Overview

6.6.3 Pfizer Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Pfizer Aminoglycosides Antibiotics Product Portfolio

6.7.5 Pfizer Recent Developments/Updates

6.8 Fresenius Kabi

6.8.1 Fresenius Kabi Corporation Information

6.8.2 Fresenius Kabi Description and Business Overview

6.8.3 Fresenius Kabi Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Fresenius Kabi Aminoglycosides Antibiotics Product Portfolio

6.8.5 Fresenius Kabi Recent Developments/Updates

6.9 Sun Pharma

6.9.1 Sun Pharma Corporation Information

6.9.2 Sun Pharma Description and Business Overview

6.9.3 Sun Pharma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2017-2022)

6.9.4 Sun Pharma Aminoglycosides Antibiotics Product Portfolio

6.9.5 Sun Pharma Recent Developments/Updates

6.10 Hikma

6.10.1 Hikma Corporation Information

6.10.2 Hikma Description and Business Overview

6.10.3 Hikma Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2017-2022)

6.10.4 Hikma Aminoglycosides Antibiotics Product Portfolio

6.10.5 Hikma Recent Developments/Updates

6.11 Lannett Company

6.11.1 Lannett Company Corporation Information

6.11.2 Lannett Company Aminoglycosides Antibiotics Description and Business Overview

6.11.3 Lannett Company Aminoglycosides Antibiotics Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Lannett Company Aminoglycosides Antibiotics Product Portfolio

6.11.5 Lannett Company Recent Developments/Updates

7 Aminoglycosides Antibiotics Manufacturing Cost Analysis

7.1 Aminoglycosides Antibiotics Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Aminoglycosides Antibiotics

7.4 Aminoglycosides Antibiotics Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Aminoglycosides Antibiotics Distributors List

8.3 Aminoglycosides Antibiotics Customers

9 Aminoglycosides Antibiotics Market Dynamics

9.1 Aminoglycosides Antibiotics Industry Trends

9.2 Aminoglycosides Antibiotics Market Drivers

9.3 Aminoglycosides Antibiotics Market Challenges

9.4 Aminoglycosides Antibiotics Market Restraints

10 Global Market Forecast

10.1 Aminoglycosides Antibiotics Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Aminoglycosides Antibiotics by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Aminoglycosides Antibiotics by Type (2023-2028)

10.2 Aminoglycosides Antibiotics Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Aminoglycosides Antibiotics by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Aminoglycosides Antibiotics by Application (2023-2028)

10.3 Aminoglycosides Antibiotics Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Aminoglycosides Antibiotics by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Aminoglycosides Antibiotics by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer